Structure

Physi-Chem Properties

Molecular Weight:  622.31
Volume:  649.734
LogP:  4.831
LogD:  3.78
LogS:  -4.934
# Rotatable Bonds:  14
TPSA:  114.43
# H-Bond Aceptor:  9
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.125
Synthetic Accessibility Score:  5.687
Fsp3:  0.556
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.863
MDCK Permeability:  0.0001040189599734731
Pgp-inhibitor:  0.999
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.891
30% Bioavailability (F30%):  0.921

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.117
Plasma Protein Binding (PPB):  95.7132339477539%
Volume Distribution (VD):  3.236
Pgp-substrate:  4.666935920715332%

ADMET: Metabolism

CYP1A2-inhibitor:  0.057
CYP1A2-substrate:  0.047
CYP2C19-inhibitor:  0.369
CYP2C19-substrate:  0.128
CYP2C9-inhibitor:  0.827
CYP2C9-substrate:  0.065
CYP2D6-inhibitor:  0.038
CYP2D6-substrate:  0.097
CYP3A4-inhibitor:  0.848
CYP3A4-substrate:  0.548

ADMET: Excretion

Clearance (CL):  3.931
Half-life (T1/2):  0.034

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.664
Drug-inuced Liver Injury (DILI):  0.962
AMES Toxicity:  0.704
Rat Oral Acute Toxicity:  0.75
Maximum Recommended Daily Dose:  0.936
Skin Sensitization:  0.402
Carcinogencity:  0.464
Eye Corrosion:  0.005
Eye Irritation:  0.048
Respiratory Toxicity:  0.953

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473216

Natural Product ID:  NPC473216
Common Name*:   [(5R,6As,7R,8R,10S,10As)-1,3-Diacetyloxy-7,8-Dimethyl-5-(2-Methylbutanoyloxy)-7-[(2E)-3-Methylpenta-2,4-Dienyl]-1,3,5,6,6A,8,9,10-Octahydrobenzo[D][2]Benzofuran-10-Yl] Benzoate
IUPAC Name:   [(5R,6aS,7R,8R,10S,10aS)-1,3-diacetyloxy-7,8-dimethyl-5-(2-methylbutanoyloxy)-7-[(2E)-3-methylpenta-2,4-dienyl]-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-10-yl] benzoate
Synonyms:  
Standard InCHIKey:  FLLKSIKUPUMYAK-LCXPLBHPSA-N
Standard InCHI:  InChI=1S/C36H46O9/c1-9-21(3)16-17-35(8)23(5)18-30(44-32(40)26-14-12-11-13-15-26)36-28(33(41-24(6)37)45-34(36)42-25(7)38)19-27(20-29(35)36)43-31(39)22(4)10-2/h9,11-16,19,22-23,27,29-30,33-34H,1,10,17-18,20H2,2-8H3/b21-16+/t22?,23-,27+,29+,30+,33?,34?,35-,36-/m1/s1
SMILES:  C=C/C(=C/C[C@]1(C)[C@H](C)C[C@@H]([C@@]23[C@H]1C[C@@H](OC(=O)C(CC)C)C=C3C(OC2OC(=O)C)OC(=O)C)OC(=O)c1ccccc1)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL372757
PubChem CID:   44404750
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[16168652]
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Activity = 27.3 uM PMID[545606]
NPT83 Cell Line MCF7 Homo sapiens Ratio = 4.6 n.a. PMID[545606]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 4.66 uM PMID[545606]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 5.35 uM PMID[545606]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis Activity > 200.0 uM PMID[545606]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473216 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC473399
0.9154 High Similarity NPC147561
0.8971 High Similarity NPC475400
0.8955 High Similarity NPC472577
0.8955 High Similarity NPC291638
0.8955 High Similarity NPC195647
0.8955 High Similarity NPC17877
0.8955 High Similarity NPC66761
0.8944 High Similarity NPC162569
0.8944 High Similarity NPC35160
0.8881 High Similarity NPC474608
0.8872 High Similarity NPC471880
0.8872 High Similarity NPC472394
0.8846 High Similarity NPC470818
0.8832 High Similarity NPC183270
0.8832 High Similarity NPC200592
0.8832 High Similarity NPC476094
0.8832 High Similarity NPC477904
0.8832 High Similarity NPC473613
0.8832 High Similarity NPC473081
0.8832 High Similarity NPC473085
0.8832 High Similarity NPC147880
0.8832 High Similarity NPC473060
0.8832 High Similarity NPC473109
0.8832 High Similarity NPC4341
0.8832 High Similarity NPC473112
0.8832 High Similarity NPC48017
0.8832 High Similarity NPC43241
0.8832 High Similarity NPC184747
0.8832 High Similarity NPC473758
0.8832 High Similarity NPC211137
0.8824 High Similarity NPC475373
0.8811 High Similarity NPC116292
0.8811 High Similarity NPC87630
0.8811 High Similarity NPC179128
0.8811 High Similarity NPC267469
0.8803 High Similarity NPC469448
0.8768 High Similarity NPC16912
0.8759 High Similarity NPC210591
0.8759 High Similarity NPC475652
0.8759 High Similarity NPC214550
0.875 High Similarity NPC472372
0.875 High Similarity NPC472374
0.875 High Similarity NPC472658
0.875 High Similarity NPC472657
0.874 High Similarity NPC470814
0.8712 High Similarity NPC230331
0.8696 High Similarity NPC90614
0.8696 High Similarity NPC472547
0.8696 High Similarity NPC97667
0.8696 High Similarity NPC171207
0.8686 High Similarity NPC283375
0.8686 High Similarity NPC183122
0.8662 High Similarity NPC208293
0.8643 High Similarity NPC246480
0.8643 High Similarity NPC147217
0.8643 High Similarity NPC473673
0.8643 High Similarity NPC270498
0.8643 High Similarity NPC191082
0.8643 High Similarity NPC177340
0.8643 High Similarity NPC475429
0.8643 High Similarity NPC139067
0.8633 High Similarity NPC41481
0.8633 High Similarity NPC87448
0.8633 High Similarity NPC97947
0.8633 High Similarity NPC118080
0.8633 High Similarity NPC472576
0.8633 High Similarity NPC291599
0.8633 High Similarity NPC27377
0.8613 High Similarity NPC472545
0.8613 High Similarity NPC472551
0.8611 High Similarity NPC469415
0.8603 High Similarity NPC48929
0.8593 High Similarity NPC238370
0.8592 High Similarity NPC474935
0.8582 High Similarity NPC125106
0.8582 High Similarity NPC476974
0.8582 High Similarity NPC57628
0.8582 High Similarity NPC95265
0.8582 High Similarity NPC95810
0.8582 High Similarity NPC472570
0.8582 High Similarity NPC470231
0.8582 High Similarity NPC51314
0.8582 High Similarity NPC67777
0.8582 High Similarity NPC472573
0.8582 High Similarity NPC11685
0.8582 High Similarity NPC188865
0.8582 High Similarity NPC25768
0.8582 High Similarity NPC163719
0.8582 High Similarity NPC472569
0.8582 High Similarity NPC70716
0.8571 High Similarity NPC472546
0.8571 High Similarity NPC34012
0.8562 High Similarity NPC469422
0.8562 High Similarity NPC34066
0.8561 High Similarity NPC470816
0.8561 High Similarity NPC100913
0.8561 High Similarity NPC275592
0.8551 High Similarity NPC39549
0.8542 High Similarity NPC303429
0.8542 High Similarity NPC222102
0.8521 High Similarity NPC470159
0.8521 High Similarity NPC472568
0.8521 High Similarity NPC171525
0.8521 High Similarity NPC158663
0.8521 High Similarity NPC472575
0.8521 High Similarity NPC469349
0.8521 High Similarity NPC472571
0.8521 High Similarity NPC470157
0.8521 High Similarity NPC96903
0.8521 High Similarity NPC471104
0.8521 High Similarity NPC70403
0.8521 High Similarity NPC200471
0.8521 High Similarity NPC476973
0.8521 High Similarity NPC472572
0.8521 High Similarity NPC184817
0.8521 High Similarity NPC177940
0.8521 High Similarity NPC473088
0.8521 High Similarity NPC174982
0.8521 High Similarity NPC29704
0.8519 High Similarity NPC475478
0.8519 High Similarity NPC470278
0.8514 High Similarity NPC476784
0.8511 High Similarity NPC191387
0.8511 High Similarity NPC131966
0.8511 High Similarity NPC163087
0.85 High Similarity NPC224491
0.8493 Intermediate Similarity NPC133430
0.8493 Intermediate Similarity NPC469477
0.8489 Intermediate Similarity NPC472395
0.8489 Intermediate Similarity NPC472371
0.8462 Intermediate Similarity NPC469513
0.8462 Intermediate Similarity NPC50872
0.8456 Intermediate Similarity NPC475493
0.8456 Intermediate Similarity NPC477623
0.8451 Intermediate Similarity NPC475759
0.8451 Intermediate Similarity NPC470152
0.8451 Intermediate Similarity NPC241951
0.8451 Intermediate Similarity NPC475122
0.8446 Intermediate Similarity NPC469417
0.8435 Intermediate Similarity NPC469398
0.8433 Intermediate Similarity NPC195224
0.8421 Intermediate Similarity NPC275576
0.8411 Intermediate Similarity NPC329960
0.8411 Intermediate Similarity NPC150893
0.8411 Intermediate Similarity NPC295408
0.8409 Intermediate Similarity NPC470815
0.8403 Intermediate Similarity NPC281717
0.8392 Intermediate Similarity NPC471100
0.8392 Intermediate Similarity NPC472556
0.8392 Intermediate Similarity NPC471107
0.8389 Intermediate Similarity NPC469399
0.838 Intermediate Similarity NPC91703
0.8369 Intermediate Similarity NPC266374
0.8358 Intermediate Similarity NPC473220
0.8358 Intermediate Similarity NPC470753
0.8358 Intermediate Similarity NPC169913
0.8345 Intermediate Similarity NPC301556
0.8345 Intermediate Similarity NPC270590
0.8345 Intermediate Similarity NPC266265
0.8345 Intermediate Similarity NPC476975
0.8345 Intermediate Similarity NPC92293
0.8345 Intermediate Similarity NPC471101
0.8333 Intermediate Similarity NPC203486
0.8333 Intermediate Similarity NPC473602
0.8322 Intermediate Similarity NPC38696
0.8311 Intermediate Similarity NPC5115
0.8311 Intermediate Similarity NPC469456
0.831 Intermediate Similarity NPC192658
0.831 Intermediate Similarity NPC475135
0.8299 Intermediate Similarity NPC472548
0.8298 Intermediate Similarity NPC87934
0.8298 Intermediate Similarity NPC162613
0.8288 Intermediate Similarity NPC254558
0.8288 Intermediate Similarity NPC475417
0.8288 Intermediate Similarity NPC475561
0.8288 Intermediate Similarity NPC470245
0.8288 Intermediate Similarity NPC473214
0.8288 Intermediate Similarity NPC476173
0.8286 Intermediate Similarity NPC327511
0.8286 Intermediate Similarity NPC205305
0.8284 Intermediate Similarity NPC100402
0.8284 Intermediate Similarity NPC9180
0.8284 Intermediate Similarity NPC473082
0.8284 Intermediate Similarity NPC470765
0.8276 Intermediate Similarity NPC320734
0.8273 Intermediate Similarity NPC477893
0.8271 Intermediate Similarity NPC469742
0.8261 Intermediate Similarity NPC472656
0.8252 Intermediate Similarity NPC477894
0.8248 Intermediate Similarity NPC472418
0.8248 Intermediate Similarity NPC72915
0.8244 Intermediate Similarity NPC473243
0.8243 Intermediate Similarity NPC471135
0.8239 Intermediate Similarity NPC77493
0.8231 Intermediate Similarity NPC470153
0.8231 Intermediate Similarity NPC51602
0.8227 Intermediate Similarity NPC121268
0.8227 Intermediate Similarity NPC53361
0.8227 Intermediate Similarity NPC9905

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473216 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8089 Intermediate Similarity NPD7799 Discontinued
0.8043 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7891 Intermediate Similarity NPD7236 Approved
0.7812 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7752 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD7239 Suspended
0.7574 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD8407 Phase 2
0.7462 Intermediate Similarity NPD2182 Approved
0.7455 Intermediate Similarity NPD8368 Discontinued
0.7447 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD7057 Phase 3
0.7296 Intermediate Similarity NPD7058 Phase 2
0.7292 Intermediate Similarity NPD7008 Discontinued
0.726 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6858 Approved
0.7239 Intermediate Similarity NPD7094 Approved
0.7214 Intermediate Similarity NPD6287 Discontinued
0.7197 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD5126 Approved
0.7194 Intermediate Similarity NPD5125 Phase 3
0.7154 Intermediate Similarity NPD164 Approved
0.7135 Intermediate Similarity NPD8434 Phase 2
0.7135 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7458 Discontinued
0.7132 Intermediate Similarity NPD5951 Approved
0.7123 Intermediate Similarity NPD3764 Approved
0.7115 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD1238 Approved
0.7107 Intermediate Similarity NPD37 Approved
0.7081 Intermediate Similarity NPD4967 Phase 2
0.7081 Intermediate Similarity NPD4965 Approved
0.7081 Intermediate Similarity NPD4966 Approved
0.7075 Intermediate Similarity NPD7961 Discontinued
0.7063 Intermediate Similarity NPD7819 Suspended
0.7059 Intermediate Similarity NPD4628 Phase 3
0.7059 Intermediate Similarity NPD8313 Approved
0.7059 Intermediate Similarity NPD8166 Discontinued
0.7059 Intermediate Similarity NPD8312 Approved
0.7052 Intermediate Similarity NPD8361 Approved
0.7052 Intermediate Similarity NPD8360 Approved
0.7052 Intermediate Similarity NPD8435 Approved
0.7051 Intermediate Similarity NPD6273 Approved
0.705 Intermediate Similarity NPD7741 Discontinued
0.7012 Intermediate Similarity NPD8127 Discontinued
0.7007 Intermediate Similarity NPD2629 Approved
0.6994 Remote Similarity NPD6234 Discontinued
0.6977 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6959 Remote Similarity NPD8032 Phase 2
0.6957 Remote Similarity NPD8455 Phase 2
0.6954 Remote Similarity NPD3748 Approved
0.695 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6948 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6559 Discontinued
0.6918 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6912 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7228 Approved
0.689 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6879 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6871 Remote Similarity NPD6832 Phase 2
0.6863 Remote Similarity NPD7266 Discontinued
0.6846 Remote Similarity NPD6663 Approved
0.6846 Remote Similarity NPD7713 Phase 3
0.6842 Remote Similarity NPD7685 Pre-registration
0.6839 Remote Similarity NPD7003 Approved
0.6835 Remote Similarity NPD4198 Discontinued
0.6815 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6803 Remote Similarity NPD5736 Approved
0.68 Remote Similarity NPD2979 Phase 3
0.6797 Remote Similarity NPD2438 Suspended
0.6796 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6774 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6772 Remote Similarity NPD2532 Approved
0.6772 Remote Similarity NPD2534 Approved
0.6772 Remote Similarity NPD2533 Approved
0.6772 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6765 Remote Similarity NPD2067 Discontinued
0.6761 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6753 Remote Similarity NPD2346 Discontinued
0.6753 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6748 Remote Similarity NPD5761 Phase 2
0.6748 Remote Similarity NPD5760 Phase 2
0.6744 Remote Similarity NPD7240 Approved
0.6735 Remote Similarity NPD2798 Approved
0.6731 Remote Similarity NPD3750 Approved
0.6727 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6708 Remote Similarity NPD3226 Approved
0.6708 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6706 Remote Similarity NPD3818 Discontinued
0.6692 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6692 Remote Similarity NPD1930 Approved
0.6692 Remote Similarity NPD1929 Approved
0.669 Remote Similarity NPD3972 Approved
0.669 Remote Similarity NPD9545 Approved
0.6688 Remote Similarity NPD2796 Approved
0.6688 Remote Similarity NPD2935 Discontinued
0.6667 Remote Similarity NPD7028 Phase 2
0.6667 Remote Similarity NPD2569 Approved
0.6667 Remote Similarity NPD2567 Approved
0.6667 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7768 Phase 2
0.6667 Remote Similarity NPD6599 Discontinued
0.6667 Remote Similarity NPD969 Suspended
0.6648 Remote Similarity NPD8150 Discontinued
0.6647 Remote Similarity NPD6765 Approved
0.6647 Remote Similarity NPD5494 Approved
0.6647 Remote Similarity NPD6764 Approved
0.6646 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6005 Phase 3
0.6645 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6004 Phase 3
0.6645 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6002 Phase 3
0.6642 Remote Similarity NPD5909 Discontinued
0.663 Remote Similarity NPD8485 Approved
0.6627 Remote Similarity NPD7075 Discontinued
0.6623 Remote Similarity NPD2799 Discontinued
0.6621 Remote Similarity NPD1281 Approved
0.662 Remote Similarity NPD7610 Discontinued
0.6618 Remote Similarity NPD6686 Approved
0.6615 Remote Similarity NPD1989 Approved
0.6607 Remote Similarity NPD7199 Phase 2
0.6606 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6599 Remote Similarity NPD1876 Approved
0.6597 Remote Similarity NPD17 Approved
0.6594 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6591 Remote Similarity NPD2066 Phase 3
0.6591 Remote Similarity NPD7798 Approved
0.6589 Remote Similarity NPD1202 Approved
0.6581 Remote Similarity NPD5408 Approved
0.6581 Remote Similarity NPD5404 Approved
0.6581 Remote Similarity NPD5406 Approved
0.6581 Remote Similarity NPD5405 Approved
0.6579 Remote Similarity NPD4307 Phase 2
0.6575 Remote Similarity NPD6637 Approved
0.6571 Remote Similarity NPD6010 Discontinued
0.657 Remote Similarity NPD5844 Phase 1
0.6567 Remote Similarity NPD6647 Phase 2
0.6565 Remote Similarity NPD3495 Discontinued
0.6559 Remote Similarity NPD8319 Approved
0.6559 Remote Similarity NPD8320 Phase 1
0.6558 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6556 Remote Similarity NPD2313 Discontinued
0.655 Remote Similarity NPD7473 Discontinued
0.6544 Remote Similarity NPD6685 Approved
0.6536 Remote Similarity NPD1933 Approved
0.6536 Remote Similarity NPD6355 Discontinued
0.6536 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6532 Remote Similarity NPD7074 Phase 3
0.6529 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6528 Remote Similarity NPD5585 Approved
0.6528 Remote Similarity NPD5691 Approved
0.6528 Remote Similarity NPD3024 Approved
0.6528 Remote Similarity NPD3025 Approved
0.6525 Remote Similarity NPD690 Clinical (unspecified phase)
0.6524 Remote Similarity NPD7411 Suspended
0.6519 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6516 Remote Similarity NPD7305 Phase 1
0.6512 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6503 Remote Similarity NPD7700 Phase 2
0.6503 Remote Similarity NPD7699 Phase 2
0.6497 Remote Similarity NPD6785 Approved
0.6497 Remote Similarity NPD6784 Approved
0.6497 Remote Similarity NPD970 Clinical (unspecified phase)
0.6492 Remote Similarity NPD8462 Phase 1
0.649 Remote Similarity NPD6039 Approved
0.6486 Remote Similarity NPD1283 Approved
0.6486 Remote Similarity NPD2198 Approved
0.6486 Remote Similarity NPD2199 Approved
0.6485 Remote Similarity NPD6801 Discontinued
0.6483 Remote Similarity NPD2932 Approved
0.6481 Remote Similarity NPD920 Approved
0.6478 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6474 Remote Similarity NPD2531 Phase 2
0.6474 Remote Similarity NPD7054 Approved
0.6471 Remote Similarity NPD4140 Approved
0.6471 Remote Similarity NPD6232 Discontinued
0.6467 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6463 Remote Similarity NPD1608 Approved
0.6463 Remote Similarity NPD4380 Phase 2
0.6452 Remote Similarity NPD7097 Phase 1
0.6447 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6447 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6443 Remote Similarity NPD3266 Approved
0.6443 Remote Similarity NPD2797 Approved
0.6443 Remote Similarity NPD3267 Approved
0.6438 Remote Similarity NPD3026 Approved
0.6438 Remote Similarity NPD3023 Approved
0.6437 Remote Similarity NPD7472 Approved
0.6436 Remote Similarity NPD7999 Approved
0.6433 Remote Similarity NPD1471 Phase 3
0.6429 Remote Similarity NPD6535 Approved
0.6429 Remote Similarity NPD230 Phase 1
0.6429 Remote Similarity NPD6534 Approved
0.6424 Remote Similarity NPD7055 Discontinued
0.642 Remote Similarity NPD7314 Clinical (unspecified phase)
0.642 Remote Similarity NPD7808 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data